Equillium Inc.

06/07/2021 | Press release | Distributed by Public on 06/07/2021 06:04

Equillium to Collaborate with Oxford University and Kennedy Institute of Rheumatology to Investigate Role of the CD6-ALCAM Pathway and Itolizumab in Rheumatic Diseases